CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −11,756 | $15.61 | $184K | 1,499,747 |
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −2,300 | $16.26 | $37K | 1,497,447 |
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −36,216 | $14.76 | $534K | 1,512,283 |
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −11,523 | $15.62 | $180K | 1,500,760 |
| 2024-08-20 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −2,261 | $16.25 | $37K | 1,498,499 |
| 2024-08-19 | Karas Eric Chief Commercial Officer | Option exercise 10b5-1 | +10,000 | $1.50 | $15K | 15,693 |
| 2024-08-19 | Karas Eric Chief Commercial Officer | Sale 10b5-1 | −10,000 | $14.00 | $140K | 5,693 |
| 2024-08-19 | Karas Eric Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 604,588 | ||
| 2024-08-13 | Dorsey Brian Chief Operating Officer | Option exercise 10b5-1 | +30,000 | $0.64 | $19K | 36,024 |
| 2024-08-13 | Dorsey Brian Chief Operating Officer | Sale 10b5-1 | −30,000 | $13.00 | $390K | 6,024 |
| 2024-08-13 | Dorsey Brian Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 111,828 | ||
| 2024-08-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −14,599 | $11.78 | $172K | 1,481,895 |
| 2024-08-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −35,401 | $12.76 | $452K | 1,446,494 |
| 2024-08-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −14,637 | $11.77 | $172K | 1,583,862 |
| 2024-08-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −35,363 | $12.77 | $451K | 1,548,499 |
| 2024-08-13 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −14,599 | $11.78 | $172K | 1,481,895 |
| 2024-08-13 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −35,401 | $12.76 | $452K | 1,446,494 |
| 2024-08-13 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −14,637 | $11.77 | $172K | 1,583,862 |
| 2024-08-13 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −35,363 | $12.77 | $451K | 1,548,499 |
| 2024-07-16 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.40 | $570K | 1,547,447 |
Page 13 of 14 · 267 trades